Medicare Enrolled

Dr. Chiayu Chen, MD

Nuclear Cardiology Physician · Riverside, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3380 LA SIERRA AVE STE 104-170, Riverside, CA 92503
2135376481
In practice since 2006 (20 years)
NPI: 1972583821 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chen

Dr. Chiayu Chen is a nuclear cardiology physician in Riverside, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chen performed 48,031 Medicare services across 1,447 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chen received a total of $58,820 from 46 pharmaceutical and/or device companies across 680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in CA $58,820 industry payments

Medicare Practice Summary

Medicare Utilization ↗
48,031
Medicare services
Top 5% in CA for nuclear cardiology physician
1,447
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,402 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Inclisiran injection (Leqvio) for cholesterol 46,292 $9 $28
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
585 $89 $341
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
325 $128 $475
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
165 $12 $37
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
143 $143 $548
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
98 $11 $39
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
80 $66 $185
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
79 $62 $240
Pacemaker programming, dual lead system
Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings.
60 $57 $209
2-day continuous ECG with review and report
A two-day continuous electrocardiogram recording that includes a professional review and written report of the results.
54 $50 $213
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
51 $141 $540
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
29 $21 $67
30-day continuous ECG with patient-triggered event transmission and review
This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report.
29 $728 $1,908
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
28 $108 $351
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $112 $440
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
96.8% medium
2.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$58,820
Total received (2018-2024)
Avg $8,403/year across 7 years
Top 5% in CA for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
680
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,000 (79.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,483 (17.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,336 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$201
2023
$1,525
2022
$8,223
2021
$20,449
2020
$3,972
2019
$2,169
2018
$22,281

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alnylam Pharmaceuticals Inc.
$125
Medtronic, Inc.
$38
Novartis Pharmaceuticals Corporation
$20
Inari Medical, Inc.
$19
Top 3 companies account for 90.7% of 2024 payments
All-time payments by company (2018-2024) ›
Esperion Therapeutics, Inc.
$26,161
Regeneron Healthcare Solutions, Inc.
$11,323
Novartis Pharmaceuticals Corporation
$6,408
Amgen Inc.
$3,312
SANOFI-AVENTIS U.S. LLC
$3,205
Boston Scientific Corporation
$1,276
AstraZeneca Pharmaceuticals LP
$1,265
Boehringer Ingelheim Pharmaceuticals, Inc.
$620
Janssen Pharmaceuticals, Inc
$482
Alnylam Pharmaceuticals Inc.
$479
Medtronic Vascular, Inc.
$466
Astellas Pharma US Inc
$423
Amarin Pharma Inc.
$406
PFIZER INC.
$390
Merck Sharp & Dohme LLC
$351
E.R. Squibb & Sons, L.L.C.
$326
Kowa Pharmaceuticals America, Inc.
$223
Abbott Laboratories
$223
Bayer Healthcare Pharmaceuticals Inc.
$160
Medtronic, Inc.
$145
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$115
Novo Nordisk Inc
$109
Daiichi Sankyo Inc.
$99
Actelion Pharmaceuticals US, Inc.
$97
Philips Electronics North America Corporation
$95
Merck Sharp & Dohme Corporation
$65
CVRx, Inc.
$65
Relypsa, Inc.
$63
ARBOR PHARMACEUTICALS, INC.
$54
BIOTRONIK INC.
$49
Akcea Therapeutics, Inc.
$46
ARALEZ PHARMACEUTICALS US INC.
$40
ABIOMED
$39
Baxter Healthcare
$29
Gilead Sciences, Inc.
$28
Arbor Pharmaceuticals, Inc.
$26
iRhythm Technologies, Inc.
$23
BOSTON SCIENTIFIC CORPORATION
$20
Inari Medical, Inc.
$19
Kiniksa Pharmaceuticals, Ltd.
$18
Braemar Manufacturing, LLC
$18
W. L. Gore & Associates, Inc.
$16
InfoBionic, Inc
$14
Allergan Inc.
$14
Avinger Inc.
$13
Travere Therapeutics, Inc.
$1
Top 3 companies account for 74.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · AMVUTTRA · ARCTIC FRONT ADVANCE · Arcalyst · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Cholbam · Cobalt · CoreValve Evolut · Corlanor · DISEASE STATE · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FLOWTRIEVER CATHETER · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LYRICA · LifeVest · Livalo · MULTAQ · Mitra Clip system · MoMe Kardia · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · Ozempic · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Rybelsus · S · STEGLATRO · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Victoza · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nuclear cardiology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for nuclear cardiology physician in CA.

Looking for a nuclear cardiology physician in Riverside?
Compare nuclear cardiology physicians in the Riverside area by procedure volume, costs, and industry payment transparency.
Browse nuclear cardiology physicians nearby

Geographic Context

Nuclear cardiology physicians within 10 mi
4
Per 100K population
0.2
County median income
$89,672
Nearest hospital
PARKVIEW COMMUNITY HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chen is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 5% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chen experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Chen performed 46,292 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chen receive payments from pharmaceutical companies?
Yes. Dr. Chen received a total of $58,820 from 46 companies across 680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chen's costs compare to other nuclear cardiology physicians in Riverside?
Dr. Chen's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →